These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38391247)

  • 1. Toward Ultrasound Molecular Imaging of Endothelial Dysfunction in Diabetes: Targets, Strategies, and Challenges.
    Liu J; Wang C; Qiu S; Sun W; Yang G; Yuan L
    ACS Appl Bio Mater; 2024 Mar; 7(3):1416-1428. PubMed ID: 38391247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial Microparticles Act as Novel Diagnostic and Therapeutic Biomarkers of Diabetes and Its Complications: A Literature Review.
    Deng F; Wang S; Zhang L
    Biomed Res Int; 2016; 2016():9802026. PubMed ID: 27803933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes-associated macrovasculopathy: pathophysiology and pathogenesis.
    Rahman S; Rahman T; Ismail AA; Rashid AR
    Diabetes Obes Metab; 2007 Nov; 9(6):767-80. PubMed ID: 17924861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic Vasculopathy: Molecular Mechanisms and Clinical Insights.
    Jia G; Bai H; Mather B; Hill MA; Jia G; Sowers JR
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound molecular imaging of vascular endothelial growth factor receptor 2 expression for endometrial receptivity evaluation.
    Liu H; Chen Y; Yan F; Han X; Wu J; Liu X; Zheng H
    Theranostics; 2015; 5(2):206-17. PubMed ID: 25553109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-peptide replacement therapy as an emerging strategy for preventing diabetic vasculopathy.
    Bhatt MP; Lim YC; Ha KS
    Cardiovasc Res; 2014 Nov; 104(2):234-44. PubMed ID: 25239825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of inflammatory and vascular endothelial dysfunction biomarkers in microvascular and macrovascular complications in type 1 diabetes.
    Wołoszyn-Durkiewicz A; Myśliwiec M
    Pediatr Endocrinol Diabetes Metab; 2019; 25(1):28-35. PubMed ID: 31343130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial dysfunction in children with type 1 diabetes mellitus.
    Pomilio M; Mohn A; Verrotti A; Chiarelli F
    J Pediatr Endocrinol Metab; 2002 Apr; 15(4):343-61. PubMed ID: 12008680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of Vascular Complications in Diabetes Mellitus Patients: Focus on the Arterial Wall.
    Lunder M; Janić M; Šabovič M
    Curr Vasc Pharmacol; 2019; 17(1):6-15. PubMed ID: 29412116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common mechanisms underlying diabetic vascular complications: focus on the interaction of metabolic disorders, immuno-inflammation, and endothelial dysfunction.
    Xue C; Chen K; Gao Z; Bao T; Dong L; Zhao L; Tong X; Li X
    Cell Commun Signal; 2023 Oct; 21(1):298. PubMed ID: 37904236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic targets in diabetic vasculopathy].
    Sánchez Ferrer CF
    An R Acad Nac Med (Madr); 2003; 120(4):659-69; discussion 669-74. PubMed ID: 15147053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular complexities underlying the vascular complications of diabetes mellitus - A comprehensive review.
    Paul S; Ali A; Katare R
    J Diabetes Complications; 2020 Aug; 34(8):107613. PubMed ID: 32505477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular Damage in Obesity and Diabetes: Highlighting Links Between Endothelial Dysfunction and Metabolic Disease in Zebrafish and Man.
    Wiggenhauser LM; Kroll J
    Curr Vasc Pharmacol; 2019; 17(5):476-490. PubMed ID: 30378499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial dysfunction in vascular complications of diabetes: a comprehensive review of mechanisms and implications.
    Yang DR; Wang MY; Zhang CL; Wang Y
    Front Endocrinol (Lausanne); 2024; 15():1359255. PubMed ID: 38645427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs in control of gene regulatory programs in diabetic vasculopathy.
    Pei C; Zhang X; Meng S; Li Y
    Front Biosci (Landmark Ed); 2017 Jan; 22(3):451-464. PubMed ID: 27814624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature.
    Nalysnyk L; Hernandez-Medina M; Krishnarajah G
    Diabetes Obes Metab; 2010 Apr; 12(4):288-98. PubMed ID: 20380649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil extracellular traps: The core player in vascular complications of diabetes mellitus.
    Berezin A
    Diabetes Metab Syndr; 2019; 13(5):3017-3023. PubMed ID: 30030160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic regulation in diabetic vascular complications.
    Jin J; Wang X; Zhi X; Meng D
    J Mol Endocrinol; 2019 Nov; 63(4):R103-R115. PubMed ID: 31600719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex differences in micro- and macro-vascular complications of diabetes mellitus.
    Maric-Bilkan C
    Clin Sci (Lond); 2017 May; 131(9):833-846. PubMed ID: 28424377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SCUBE2, vascular endothelium, and vascular complications: A systematic review.
    Ali H
    Biomed Pharmacother; 2020 Jul; 127():110129. PubMed ID: 32278240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.